Alvotech prices EEA private placement at USD 67 million at USD 3.75 a share

Alvotech

Alvotech

ALVO

0.00
  • Alvotech priced an unregistered share sale to EEA professional investors, issuing 17,826,666 common shares at USD 3.75 each.
  • Gross proceeds set at about USD 67 million; closing expected around June 25.
  • Transaction ran alongside a U.S. underwritten offering, bringing total gross proceeds to about USD 165 million.
  • Total new shares across both deals set at 43,893,333; total shares outstanding to rise to 390,431,480.
  • Proceeds earmarked for biosimilar development, working capital, operating costs, capital spending, partnerships, clinical work, product launches, debt repayment or refinancing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606180400OMX_____CNEWS_IS_GNW1001188415_is) on June 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.